ao. Univ.-Prof. Mag. Dr. Michael Wirth
T: +43-1-4277-55407
Winter term 2025
321000 OV Infoveranstaltung - Pharmazie
321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)
321037 VU Pharmazeutische Wissenschaften - B20
Summer term 2025
321000 OV Infoveranstaltung - Pharmazie
321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)
321037 VU Pharmazeutische Wissenschaften - B20
323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)
Winter term 2024
321000 OV Infoveranstaltung - Pharmazie
321034 PR Produktionsprozesse und Qualitätskontrolle in der Pharmazeutischen Technologie - B18 - (6 Kurse)
321037 VU Pharmazeutische Wissenschaften - B20
Skoll K, Palmetzhofer J, Lummerstorfer M, Anzengruber M, Gabor F, Wirth M. Human serum albumin nanoparticles as a versatile vehicle for targeted delivery of antibiotics to combat bacterial infections. Nanomedicine - Nanotechnology Biology and Medicine. 2023 Jun 1;50:102685. doi: 10.1016/j.nano.2023.102685
Anzengruber M, Nepustil LM, Kurtaj F, Tahir A, Skoll K, Sami H et al. A Versatile Brij-Linker for One-Step Preparation of Targeted Nanoparticles. Pharmaceutics. 2023 May;15(5):1403. doi: 10.3390/pharmaceutics15051403
Gausterer JC, Schlager M, Ahmadi N, Nieratschker M, Dahm V, Wirth M et al. A Novel Preparation Technique for Human Nasal Respiratory Mucosa to Disclose Its Glycosylation Pattern for Bioadhesive Drug Delivery. Pharmaceutics. 2023 Mar 17;15(3):973. doi: 10.3390/pharmaceutics15030973
Anzengruber M, Wimmer L, Szuchar R, Skoll K, Wirth M, Gabor F. LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2023 Jan 1;180:106330. doi: 10.1016/j.ejps.2022.106330
Vater C, Bosch L, Mitter A, Göls T, Seiser S, Heiß E et al. Lecithin-based nanoemulsions of traditional herbal wound healing agents and their effect on human skin cells. European Journal of Pharmaceutics and Biopharmaceutics. 2022 Jan;170:1-9. doi: 10.1016/j.ejpb.2021.11.004
Skoll K, Ritschka M, Fuchs S, Wirth M, Gabor F. Characterization of sonochemically prepared human serum albumin nanocapsules using different plant oils as core component for targeted drug delivery. Ultrasonics. 2021 Aug;76:105617. doi: 10.1016/j.ultsonch.2021.105617
Hufnagel B, Müllner V, Hlatky K, Guebitz GM, Wirth M, Gabor F. Chemically modified inulin for intestinal drug delivery - A new dual bioactivity concept for inflammatory bowel disease treatment. Carbohydrate Polymers. 2021 Jan 15;252:117091. doi: 10.1016/j.carbpol.2020.117091
Brauner B, Semmler J, Rauch D, Nokaj M, Haiss P, Schwarz P et al. Trimethoprim-Loaded PLGA Nanoparticles Grafted with WGA as Potential Intravesical Therapy of Urinary Tract Infections-Studies on Adhesion to SV-HUCs Under Varying Time, pH, and Drug-Loading Conditions. ACS Omega. 2020 Jul 21;5(28):17377-17384. doi: 10.1021/acsomega.0c01745
Gausterer JC, Saidov N, Ahmadi N, Wirth M, Reznicek G, Arnoldner C et al. Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear. European Journal of Pharmaceutics and Biopharmaceutics. 2020 May;150:143-155. doi: 10.1016/j.ejpb.2020.03.005
Vater C, Hlawaty V, Werdenits P, Cichon MA, Klang V, Elbe-Bürger A et al. Effects of lecithin-based nanoemulsions on skin: Short-time cytotoxicity MTT and BrdU studies, skin penetration of surfactants and additives and the delivery of curcumin. International Journal of Pharmaceutics. 2020 Apr 30;580:119209. doi: 10.1016/j.ijpharm.2020.119209
Brauner B, Schuster C, Wirth M, Gabor F. Trimethoprim-loaded microspheres prepared from low-molecular-weight PLGA as a potential drug delivery system for the treatment of urinary tract infections. ACS Omega. 2020 Apr 21;5(15):9013-9022. doi: 10.1021/acsomega.0c00981
Brauner B, Schwarz P, Wirth M, Gabor F. Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections. International Journal of Pharmaceutics. 2020;579:119-158.
Vater C, Adamovic A, Ruttensteiner LM, Steiner K, Tajpara P, Klang V et al. Cytotoxicity of lecithin-based nanoemulsions on human skin cells and ex vivo skin permeation: Comparison to conventional surfactant types. International Journal of Pharmaceutics. 2019;566:383-390. doi: 10.1016/j.ijpharm.2019.05.078
Apfelthaler C, Skoll K, Ciola R, Gabor F, Wirth M. a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter. European Journal of Pharmaceutical Sciences. 2018;130:177-184.
Apfelthaler C, Gassenbauer P, Weisse S, Gabor F, Wirth M. A lectin mediated delivery system for the intravesical treatment of bladder diseases using poly-(L)-glutamic acid as polymeric backbone. European Journal of Pharmaceutical Sciences. 2018;111:376-382.
Binder L, Jatschka J, Baurecht D, Wirth M, Valenta C. Novel concentrated water-in-oil emulsions based on a non-ionic silicone surfactant: appealing application properties and tuneable viscoelasticity. European Journal of Pharmaceutics and Biopharmaceutics. 2017 Nov;120:34-42. doi: 10.1016/j.ejpb.2017.08.003
Apfelthaler C, Anzengruber M, Gabor F, Wirth M. Poly - (L) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moietly. European Journal of Pharmaceutics and Biopharmaceutics. 2017;115:131-139.
Pichl CM, Dunkl B, Brauner B, Gabor F, Wirth M, Neutsch L. Biomimickry of UPEC cytoinvasion: a novel concept for improved drug delivery in UTI. Pathogens. 2016;5(1):16. doi: 10.3390/pathogens5010016
Pichl CM, Feilhauer S, Schwaigerlehner RM, Gabor F, Wirth M, Neutsch L. Glycan-mediated uptake in urothelial Primary cells: Perspectives for improved intravesical drug delivery in urinary tract infections. International Journal of Pharmaceutics. 2015 Nov 30;495(2):710-718. doi: 10.1016/j.ijpharm.2015.09.017
Engleder E, Demmerer E, Wang X, Honeder C, Zhu C, Studenik C et al. Determination of the glycosylation-pattern of the middle ear mucosa in Guinea pigs. International Journal of Pharmaceutics. 2015 Apr 30;484(1-2):124-130. doi: 10.1016/j.ijpharm.2015.02.056
Second-generation delivery systems for intravesical therapy - Improved urothelial uptake via glycotargeted biorecognition
Wirth, M. (Contributor)
19 Mar 2012
Activity: Talks and presentations › Talk or oral contribution › Other
Lectin-mediated Drug Delivery to Improve the Intravesical Therapy of Urothelial Carcinoma
Wirth, M. (Contributor)
14 Sept 2011
Activity: Talks and presentations › Talk or oral contribution › Other
Gezielt ans maligne Urothel: Lektin-vermittelte Biorekognition für eine effizientere intravesikale Therapie
Wirth, M. (Contributor)
30 Mar 2011
Activity: Talks and presentations › Talk or oral contribution › Other
Microfluidic system to study the impact of flow on particle-cell interactions
Wirth, M. (Contributor)
20 Nov 2009
Activity: Talks and presentations › Talk or oral contribution › Other
An Acoustically-Driven Biochip: Particle-Cell Interactions under Physiological Flow Conditions
Wirth, M. (Contributor)
17 Apr 2009
Activity: Talks and presentations › Talk or oral contribution › Other
Influence of Microplate Mixing on Binding Assays
Wirth, M. (Contributor)
17 Apr 2009
Activity: Talks and presentations › Talk or oral contribution › Other
Genregulatory Effects of Sappan lignum Extract in a Cell Model of Joint Innflammation
Wirth, M. (Contributor)
16 Apr 2009
Activity: Talks and presentations › Talk or oral contribution › Other
Pluronic® F-68 enhances the nanoparticle-cell interaction
Wirth, M. (Speaker)
16 Apr 2009
Activity: Talks and presentations › Talk or oral contribution › Other
Influence of the surfactant content on nanoparticle size determination by DLS
Wirth, M. (Contributor)
16 May 2008
Activity: Talks and presentations › Talk or oral contribution › Other
Lectin-mediated targeting: Characterisation by fluorescent Bio-Nanoprobes
Wirth, M. (Contributor)
16 May 2008
Activity: Talks and presentations › Talk or oral contribution › Other
PLGA microparticles for oral allergen immunotherapy
Wirth, M. (Contributor)
6 Sept 2007
Activity: Talks and presentations › Talk or oral contribution › Other
Lectin-mediated drug targeting: binding and uptake of different lectins using bladder carcinoma cells 5637
Wirth, M. (Contributor)
21 Apr 2007
Activity: Talks and presentations › Talk or oral contribution › Other
Dynamic light scattering of nanospheres: Implications of the tenside concentration on particle size
Wirth, M. (Contributor)
20 Apr 2007
Activity: Talks and presentations › Talk or oral contribution › Other
Covalent immobilisation of PEG as a novel approach towards stealth-PLGA-nanoparticles
Wirth, M. (Contributor)
19 Oct 2006
Activity: Talks and presentations › Talk or oral contribution › Other
Biocompatibility of magnetic carriers for automated cell handling
Wirth, M. (Contributor)
7 Oct 2006
Activity: Talks and presentations › Talk or oral contribution › Other
Surface engineering of growth support to modify the characteristics of Caco-2 cells
Wirth, M. (Contributor)
7 Oct 2006
Activity: Talks and presentations › Talk or oral contribution › Other
Department of Pharmaceutical Sciences
Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2F307
T: +43-1-4277-55407